Applied DNA Sciences announced on September 17, 2024, that it has successfully regained compliance with Nasdaq's minimum bid price requirement. The company's stock maintained a closing bid price of $1.00 or higher for 20 consecutive business days from August 19 to September 16, 2024, satisfying the listing requirement under Nasdaq Rule 5550(a)(2).This development resolves the compliance issue that arose on July 12, 2024, when the company was initially notified of failing to maintain the minimum bid price requirement. Nasdaq has confirmed that the matter is now closed, ensuring Applied DNA's continued listing on the Nasdaq Capital Market.

Applied DNA Sciences announced on September 17, 2024, that it has successfully regained compliance with Nasdaq's minimum bid price requirement. The company's stock maintained a closing bid price of $1.00 or higher for 20 consecutive business days from August 19 to September 16, 2024, satisfying the listing requirement under Nasdaq Rule 5550(a)(2).This development resolves the compliance issue that arose on July 12, 2024, when the company was initially notified of failing to maintain the minimum bid price requirement. Nasdaq has confirmed that the matter is now closed, ensuring Applied DNA's continued listing on the Nasdaq Capital Market.